PURPOSE: To develop a post-processing, respiratory-motion correction algorithm for magnetic resonance spectroscopy (MRS) of the liver and to determine the incidence and impact of respiratory motion in liver MRS. MATERIALS AND METHODS: One hundred thirty-two subjects (27 healthy, 31 with nonalcoholic fatty liver disease and 74 HIV-infected with or without hepatitis C) were scanned with free breathing MRS at 1.5 T. Two spectral time series were acquired on an 8-ml single voxel using TR/TE=2500 ms/30 ms and (1) water suppression, 128 acquisitions, and (2) no water suppression, 8 acquisitions. Individual spectra were phased and frequency aligned to correct for intrahepatic motion. Next, water peaks more than 50% different from the median water peak area were identified and removed, and remaining spectra averaged to correct for presumed extrahepatic motion. Total CH(2)+CH(3) lipids to unsuppressed water ratios were compared before and after corrections. RESULTS: Intrahepatic-motion correction increased the signal to noise ratio (S/N) in all cases (median=11-fold). Presumed extrahepatic motion was present in 41% (54/132) of the subjects. Its correction altered the lipids/water magnitude (magnitude change: median=2.6%, maximum=290%, and was >5% in 25% of these subjects). The incidence and effect of respiratory motion on lipids/water magnitude were similar among the three groups. CONCLUSION: Respiratory-motion correction of free breathing liver MRS greatly increased the S/N and, in a significant number of subjects, changed the lipids/water ratios, relevant for monitoring subjects.
PURPOSE: To develop a post-processing, respiratory-motion correction algorithm for magnetic resonance spectroscopy (MRS) of the liver and to determine the incidence and impact of respiratory motion in liver MRS. MATERIALS AND METHODS: One hundred thirty-two subjects (27 healthy, 31 with nonalcoholic fatty liver disease and 74 HIV-infected with or without hepatitis C) were scanned with free breathing MRS at 1.5 T. Two spectral time series were acquired on an 8-ml single voxel using TR/TE=2500 ms/30 ms and (1) water suppression, 128 acquisitions, and (2) no water suppression, 8 acquisitions. Individual spectra were phased and frequency aligned to correct for intrahepatic motion. Next, water peaks more than 50% different from the median water peak area were identified and removed, and remaining spectra averaged to correct for presumed extrahepatic motion. Total CH(2)+CH(3) lipids to unsuppressed water ratios were compared before and after corrections. RESULTS: Intrahepatic-motion correction increased the signal to noise ratio (S/N) in all cases (median=11-fold). Presumed extrahepatic motion was present in 41% (54/132) of the subjects. Its correction altered the lipids/water magnitude (magnitude change: median=2.6%, maximum=290%, and was >5% in 25% of these subjects). The incidence and effect of respiratory motion on lipids/water magnitude were similar among the three groups. CONCLUSION: Respiratory-motion correction of free breathing liver MRS greatly increased the S/N and, in a significant number of subjects, changed the lipids/water ratios, relevant for monitoring subjects.
Authors: R Longo; P Pollesello; C Ricci; F Masutti; B J Kvam; L Bercich; L S Crocè; P Grigolato; S Paoletti; B de Bernard Journal: J Magn Reson Imaging Date: 1995 May-Jun Impact factor: 4.813
Authors: R Longo; C Ricci; F Masutti; R Vidimari; L S Crocé; L Bercich; C Tiribelli; L Dalla Palma Journal: Invest Radiol Date: 1993-04 Impact factor: 6.016
Authors: Gülin Öz; Dinesh K Deelchand; Jannie P Wijnen; Vladimír Mlynárik; Lijing Xin; Ralf Mekle; Ralph Noeske; Tom W J Scheenen; Ivan Tkáč Journal: NMR Biomed Date: 2020-01-10 Impact factor: 4.044
Authors: Jean-Marc Schwarz; Susan M Noworolski; Michael J Wen; Artem Dyachenko; Jessica L Prior; Melissa E Weinberg; Laurie A Herraiz; Viva W Tai; Nathalie Bergeron; Thomas P Bersot; Madhu N Rao; Morris Schambelan; Kathleen Mulligan Journal: J Clin Endocrinol Metab Date: 2015-03-31 Impact factor: 5.958
Authors: Jennifer C Price; Yifei Ma; Rebecca Scherzer; Natalie Korn; Kyle Tillinghast; Marion G Peters; Susan M Noworolski; Phyllis C Tien Journal: Hepatology Date: 2017-02-03 Impact factor: 17.425
Authors: Ani Kardashian; Yifei Ma; Rebecca Scherzer; Jennifer C Price; Monika Sarkar; Natalie Korn; Kyle Tillinghast; Marion G Peters; Susan M Noworolski; Phyllis C Tien Journal: AIDS Date: 2017-01-28 Impact factor: 4.177
Authors: Jennifer C Price; Jennifer L Dodge; Yifei Ma; Rebecca Scherzer; Natalie Korn; Kyle Tillinghast; Marion G Peters; Susan Noworolski; Phyllis C Tien Journal: AIDS Date: 2017-09-24 Impact factor: 4.177
Authors: Jean-Marc Schwarz; Susan M Noworolski; Ayca Erkin-Cakmak; Natalie J Korn; Michael J Wen; Viva W Tai; Grace M Jones; Sergiu P Palii; Moises Velasco-Alin; Karen Pan; Bruce W Patterson; Alejandro Gugliucci; Robert H Lustig; Kathleen Mulligan Journal: Gastroenterology Date: 2017-06-01 Impact factor: 22.682